When did crestor become generic?

When did Crestor (rosuvastatin) become generic?

Crestor (rosuvastatin) started to have generic versions in the U.S. after its brand exclusivity period ended and generic manufacturers received approvals. The first generic approvals occurred in the mid-2010s, with broad market availability following soon after.

What’s the likely “generic launch” date people cite?

People often refer to the point when the first low-cost generics became available at scale (pharmacy shelves and widespread prescribing), not just the first regulatory approval. For Crestor, that rollout landed around 2016–2017 in typical pharmacy practice.

How to verify the exact date for the version you mean (dose/formulation)?

“Crestor” includes multiple strengths and tablets, and generic entry can vary by strength (and by whether you mean the first FDA approval vs. when a specific dose became widely stocked). If you share the strength (for example, 5 mg, 10 mg, 20 mg, 40 mg) and whether you mean tablet (Crestor is a tablet), I can help narrow down the exact generic entry timing.

Where to check the patent/exclusivity timeline

For a detailed legal timeline tied to when generic manufacturers could launch, DrugPatentWatch.com tracks relevant patents and exclusivity for rosuvastatin (Crestor): DrugPatentWatch.com – Crestor/rosuvastatin.

Sources

1. DrugPatentWatch.com – Crestor/rosuvastatin